Importance Hepatocellular carcinoma (HCC) surveillance is underused in clinical practice,
which may be owing to patient and clinician barriers. Objective To characterize HCC …

Monitoring population-level colonoscopy and sigmoidoscopy use is crucial to estimate the
future burden of colorectal cancer and guide screening efforts. We conducted a systematic …

The success of fecal occult blood‐based colorectal cancer screening programs is
dependent on repeating screening at short intervals (ie, every 1‐2 years). We conducted a …

Background & Aims Hepatocellular carcinoma (HCC) screening of patients with cirrhosis is
recommended by professional societies to increase detection of early stage tumors and …

Background & Aims Reports of mailed fecal immunochemical test (FIT) outreach
effectiveness over time are minimal. We aimed to better evaluate a mailed FIT program with …

Guidelines recommend regular screening for colorectal cancer (CRC). We examined the
effects of chronic comorbidities on periodic CRC testing. Using linked healthcare databases …

Background & Aims Clinical guidelines for colorectal cancer (CRC) screening suggest use
of either stool-based tests or colonoscopy–modalities that differ in recommended screening …

Background Screening with fecal immunochemical testing (FIT) reduces colorectal cancer
mortality; however, screening remains low in underserved populations. Mailed outreach …

Background: Proportion of time covered (PTC, or “covered time”) is a longitudinal measure
of adherence to preventive health services, the use of which has increased in recent years …

Background: Colorectal cancer screening with fecal immunochemical testing (FIT) can
reduce colorectal cancer–related mortality. Effectiveness of FIT may be compromised when …